These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
838 related items for PubMed ID: 7522959
61. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer. Shain SA. Mol Urol; 2001; 5(3):121-30. PubMed ID: 11690559 [Abstract] [Full Text] [Related]
62. Molecular mechanisms in hormone-resistant prostate cancer. Roznovanu SL, Amălinci C, Rădulescu D. Rev Med Chir Soc Med Nat Iasi; 2005; 109(3):577-83. PubMed ID: 16607754 [Abstract] [Full Text] [Related]
63. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells. Ye D, Mendelsohn J, Fan Z. Clin Cancer Res; 1999 Aug; 5(8):2171-7. PubMed ID: 10473102 [Abstract] [Full Text] [Related]
64. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes. Cherian MT, Wilson EM, Shapiro DJ. J Biol Chem; 2012 Jul 06; 287(28):23368-80. PubMed ID: 22589544 [Abstract] [Full Text] [Related]
65. Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines. Shaida N, Launchbury R, Boddy JL, Jones C, Campo L, Turley H, Kanga S, Banham AH, Malone PR, Harris AL, Fox SB. Prostate; 2008 Feb 15; 68(3):336-43. PubMed ID: 18163427 [Abstract] [Full Text] [Related]
66. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Arnold JT, Liu X, Allen JD, Le H, McFann KK, Blackman MR. Prostate; 2007 Aug 01; 67(11):1152-62. PubMed ID: 17503469 [Abstract] [Full Text] [Related]
67. Use of reporter genes to study promoters of the androgen receptor. Shemshedini L. Methods Mol Biol; 2009 Aug 01; 590():195-207. PubMed ID: 19763505 [Abstract] [Full Text] [Related]
68. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells. Alexander B, Fishman AI, Green D, Choudhury MS, Konno S. Urol Oncol; 2013 Jan 01; 31(1):104-9. PubMed ID: 21795077 [Abstract] [Full Text] [Related]
69. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. Sadar MD. J Biol Chem; 1999 Mar 19; 274(12):7777-83. PubMed ID: 10075669 [Abstract] [Full Text] [Related]
70. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells. Kollara A, Diamandis EP, Brown TJ. J Steroid Biochem Mol Biol; 2003 Apr 19; 84(5):493-502. PubMed ID: 12767274 [Abstract] [Full Text] [Related]
71. The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells. Slupianek A, Yerrum S, Safadi FF, Monroy MA. J Cell Physiol; 2010 Aug 19; 224(2):369-75. PubMed ID: 20432434 [Abstract] [Full Text] [Related]
72. Effects of androgen, fibroblast growth factors or other various growth factors on growth of Shionogi carcinoma cells in a protein-free medium. Tanaka A, Lu J, Yamanishi H, Nonomura N, Yasui T, Maeyama M, Nishizawa Y, Matsumoto K, Sato B. Anticancer Res; 1990 Aug 19; 10(6):1637-41. PubMed ID: 2285236 [Abstract] [Full Text] [Related]
73. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Gioeli D, Black BE, Gordon V, Spencer A, Kesler CT, Eblen ST, Paschal BM, Weber MJ. Mol Endocrinol; 2006 Mar 19; 20(3):503-15. PubMed ID: 16282370 [Abstract] [Full Text] [Related]
74. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. Dai Y, Ngo D, Jacob J, Forman LW, Faller DV. Carcinogenesis; 2008 Sep 19; 29(9):1725-33. PubMed ID: 18487222 [Abstract] [Full Text] [Related]
75. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. Zhao XY, Peehl DM, Navone NM, Feldman D. Endocrinology; 2000 Jul 19; 141(7):2548-56. PubMed ID: 10875257 [Abstract] [Full Text] [Related]
76. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells. Shi XB, Xue L, Zou JX, Gandour-Edwards R, Chen H, deVere White RW. Prostate; 2008 Dec 01; 68(16):1816-26. PubMed ID: 18780293 [Abstract] [Full Text] [Related]
77. Associations of saposin C, Src, and androgen receptor upregulate the expression and function of androgen receptor in human prostate cancer cells. Ding Y, Wang X, Xu A, Xu X, Tian K, Young CY, Yuan H. J Cell Biochem; 2011 Mar 01; 112(3):818-28. PubMed ID: 21328455 [Abstract] [Full Text] [Related]
78. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Dai JL, Maiorino CA, Gkonos PJ, Burnstein KL. Steroids; 1996 Sep 01; 61(9):531-9. PubMed ID: 8883219 [Abstract] [Full Text] [Related]
79. Growth hormone affects gene expression and proliferation in human prostate cancer cells. Bidosee M, Karry R, Weiss-Messer E, Barkey RJ. Int J Androl; 2011 Apr 01; 34(2):124-37. PubMed ID: 20546049 [Abstract] [Full Text] [Related]
80. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells. Huo C, Kao YH, Chuu CP. Cancer Lett; 2015 Dec 01; 369(1):103-11. PubMed ID: 26297988 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]